Financials
- Market Capitalization 1.82 B
- Employee 260
- Founded 1997
- CEO N/A
- Website www.xencor.com
- Headquarter Delaware, United States
- FIGI BBG0026ZG4W0
- Industry Biyoteknoloji
Toplam gelir
Net kar
Temel hisse başına kazanç (Temel EPS)
Toplam borç
Serbest nakit akışı
Nakit ve eşdeğerleri
Fiyat/kazanç oranı
-12.35
Fiyat/satışlar oranı
9.05
Related tickers
| # | Ad | Fiyat | 24s % | 7g % | 1A % | 1Y % | Piyasa Değeri | Son 7 Gün | |
|---|---|---|---|---|---|---|---|---|---|
| 1991 | URGN UroGen Pharma Ltd. - Ordinary Shares | 38.03 USD | -0.65% | -10.43% | -10.22% | +100.16% | 1.86 B USD | ||
| 2007 | MESO Mesoblast Limited - American Depositary Shares | 14.11 USD | -1.12% | +2.32% | -6.99% | -20.69% | 1.83 B USD | ||
| 2018 | AGIO Agios Pharmaceuticals, Inc. - Common Stock | 30.45 USD | -1.20% | -4.09% | -9.99% | -29.82% | 1.82 B USD | ||
| 2019 | TRVI Trevi Therapeutics, Inc. - Common Stock | 12.67 USD | -2.01% | -6.15% | -20.81% | +32.67% | 1.81 B USD |